Cardiovascular disease: Phytochemical and nutritional prevention and treatment

Alternative and Complementary Therapies

Volumn 9, Issue 4, 2003, Pages 158-162

  Meletis, Chris D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALPHA TOCOPHEROL; ARACHIDONIC ACID; BROMELAIN; C REACTIVE PROTEIN; CAFFEIC ACID; CARBON 14; CHLOROGENIC ACID; CHOLESTEROL; CURCUMIN; CYANOCOBALAMIN; CYNARINE; CYNAROPICRIN; DOCOSAHEXAENOIC ACID; FIBRINOGEN; FISH OIL; FOLIC ACID; GARLIC EXTRACT; GLYCEROL; GUGGULSTERONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEOLIN; OMEGA 3 FATTY ACID; PHYTOSTEROL; PLANT EXTRACT; PYRIDOXINE; TRIACYLGLYCEROL; TRITIUM;

ALTERNATIVE MEDICINE; ANIMAL MODEL; ARTICHOKE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; GARLIC; HALITOSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; NUTRITION; PHYTOCHEMISTRY; RASH; REVIEW; SIDE EFFECT;

EID: 0041572918     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/107628003322256850     Document Type: Review

References (43)

1. Online document at: www.americanheart.org
2. Online document at: www.who.int/ncd/cvd
3. The Expert Panel. Summary of the second report of the national cholesterol education panel (NCEP) expert panel on detecfion, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:1421-1426,3015-3023.
4. Pagana KD, Pagana TJ. Mosby's Manual of Diagnostic and Laboratory Tests. St. Louis: Mosby, 1998.
5. Satyavati GV. Gugulipid: A promising hypolipidaemic agent from gum guggul. Econ Med Plant Res 1991;5:48-82.
6. Urizar NL, Moore DD. Gugulipid: A natural cholesterol-lowering agent. Annu Rev Nutr 2003 [epub ahead of print].
7. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid a new hypolipaedemic agent. J Assoc Phys India 1989;37:321-328.
8. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994;8:659-664.
9. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid: A new hypolipidaemic agent. J Assoc Phys India 1989;37:323-328.
10. Pizzomo ME Jr., Murray M. Encyclopedia of Natural Medicine. Rocklin, CA: Prima Publishers, 1998.
11. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: A review. Nutr J 2002;1:4.
12. Ali M, Thomson M, Afzal M. Garlic and onions: Their effect on eicosanoid metabolism and its clinical relevance. Prostaglandins Leukot Essent Fatty Acids 2000;62:55-73.
13. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia: A meta-analysis of randomized clinical trials. Ann Intern Med 2000;133:420-429.
14. Mader FH. Treatment of hyperlipidaemia with garlic-powder tablets: Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study. Arzneimittelforschung 1990;40:1111-1116.
15. Yeh YY, Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: Human and animal studies. J Nutr 2001;131(suppl.3):989S-993S.
16. Gupta N, Porter TD. Garlic and garlic-derived compounds inhibit human squalene monooxygenase. J Nutr 2001;131:1662-1667.
17. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids 1994;29:189-193.
18. Englisch W, Beckers C, Unkauf M, et al. Efficacy of artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 2000;50:260-265.
19. Gebhardt R. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts. J Pharmacol Exp Ther 1998;386:1122-1128.
20. Shimoda H, Ninomiya K, Nishida N, Yoshino T, Morikawa T, Matsuda H, Yoshikawa M. Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): Structure requirement and mode of action. Bioorg Med Chem Lett 2003;13:223-228.
21. Walker AF, Middleton RW, Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study. Phytother Res 2001;15:58-61.
22. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2nd ed. New York: John Wiley & Sons, 1996.
23. Asai A, Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 2001;131:2932-2935.
24. Wang S, Chen B, Sun C. Regulation effect of curcumin on blood lipids and antioxidation in hyperlipidemia rats [in Chinese]. Wei Sheng Yan Jiu 2000;29:240-242.
25. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003;167:73-79.
26. Koenig W. Fibrin(ogen) in cardiovascular disease: An update. Thromb Haemost 2003;89:601-609.
27. Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000;84:149-161.
28. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, Schmidt EB. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 2001;88:1139-1142.
29. Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 2003;23:27-36.
30. Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: The role of α-tocopherol therapy. Free Radic Res 2002;36:1331-1336.
31. Devaraj S, Jialal I.α-Tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 2000;29:790-792.
32. Dieber-Rotheneder M, Puhl H, Waeg G. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991;32:1325-1332.
33. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000;23:733-738.
34. Kappus H, Diplock AT. Tolerance and safety of vitamin E: A toxicological position report. Free Radic Biol Med 1992;13:55-74.
35. Steiner M, Li W. Aged garlic extract, a modulator of cardiovascular risk factors: A dose-finding study on the effects of AGE on platelet functions. J Nutr 2001;131(suppl.3):980S-984S.
36. Steiner M, Lin RS. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol 1998;31:904-908.
37. Kelly, GS. Bromelain: A literature review and discussion of [sic] its therapeutic applications. Alt Med Rev 1996;1:243-257.
38. De-Giuli M, Pirotta F. Bromelain: Interaction with some protease inhibitors and rabbit specific antiserum. Drugs Exp Clin Res 1978;4:21-23.
39. Livio M, Bertoni MP, De Gaetano G. Effect of bromelain on fibrinogen level, prothrombin complex factors and platelet aggregation in the rat - a preliminary report. Drugs Exp Clin Res 1978;4:49-53.
40. Miller AL, Kelly GS. Homocysteine metabolism: Nutritional modulation and impact on health and disease. Altern Med Rev 1997;2:234-254.
41. Graham IM, O'Callaghan P. Vitamins, homocysteine and cardiovascular risk. Cardiovasc Drugs Ther 2002;16:383-389.
42. Krishnaswamy K, Lakshmi AV. Role of nutritional supplementation in reducing the levels of homocysteine. J Assoc Physicians India 2002;50(suppl.):36-42.
43. O'Connor JJ, Meurer LN. Should patients with coronary disease and high homocysteine take folic acid? J Fam Pract 2003;52:16-18.